Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
85,061,593
-
Shares change
-
+688,209
-
Total reported value, excl. options
-
$2,474,579,740
-
Value change
-
+$22,339,643
-
Put/Call ratio
-
75%
-
Number of buys
-
83
-
Number of sells
-
88
-
Price
-
$29.09
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q1 2024
As of 31 Mar 2024 PTC THERAPEUTICS, INC. - Common Stock (PTCT) had 218 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 85,061,593 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., RTW INVESTMENTS, LP, ARMISTICE CAPITAL, LLC, STATE STREET CORP, Camber Capital Management LP, COWEN AND COMPANY, LLC, JANUS HENDERSON GROUP PLC, and MORGAN STANLEY.
This table shows 218 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.